Beckman Coulter DxU 840m and 850m Iris Recall

The Beckman Coulter DxU 840m and 850m Iris recall is a Class II FDA device recall covering 2,088 units, classified on October 15, 2026 under recall number Z-0160-2027. FDA records say a rinse-line check valve lasts less than expected and needs annual replacement. The firm excluded that valve replacement from annual preventive maintenance without an adequate reliability evaluation.

At a glance

• FDA assigned recall number Z-0160-2027 to Beckman Coulter, Inc., of Miami, Florida, for the DxU 840m Iris (REF: C76947) and DxU 850m Iris (REF: C49513).
• FDA classified the action as Class II on October 15, 2026, and the recall status is listed as Ongoing.
• The recall covers 2,088 units across all serial numbers, distributed worldwide and nationwide in the United States.
• The stated reason is that the rinse-line check valve has a shorter service lifespan than expected and requires annual replacement to prevent lamina fluid leakage.
• The action is described in the FDA record as Voluntary: Firm initiated.

What the FDA recall record says about the check valve

The reason for recall in the FDA enforcement record describes a maintenance scheduling defect rather than a single defective lot. The rinse-line check valve, a component of the instrument’s fluid pathway, lasts less time than the manufacturer originally expected. Annual replacement is the mitigation the record identifies.

The record further states that the check valve replacement was excluded from the annual preventive maintenance requirements without adequate reliability evaluation. Preventive maintenance (PM) is the scheduled service an instrument owner performs to keep a device within specification.

The record describes what can happen when the valve is not replaced annually. Lamina fluid may migrate internally and leak onto the table or floor. The record lists potential consequences as exposure to physical hazards (slip or fall), chemical hazards (lamina fluid exposure), biohazardous exposure, property damage, and delayed patient results.

Which products and serial numbers are covered

The FDA record identifies the affected products by name and reference number: DxU 840m Iris, REF: C76947, and DxU 850m Iris, REF: C49513. It also lists device identifiers: 15099590748654 for the DxU 840m and 15099590748647 for the DxU 850m.

The product quantity is 2,088, and the code information states “All Serial Numbers.” Distribution is worldwide, with US nationwide distribution listed across all 50 states plus the District of Columbia, Puerto Rico and Guam, and shipments to dozens of other countries including Canada, Mexico, Japan, Germany, France and the United Kingdom.

What is established vs. what is alleged

The record does not describe the recall as a finding of legal liability, and no court has weighed the underlying conduct in any document supplied here. The hazard language is prospective: the record describes what “may” occur, not what has been confirmed to occur.

Where the matter stands procedurally

There is no federal consolidation of claims arising from this recall in the supplied documents. Multidistrict litigation (MDL), a procedure that centralizes related federal cases before one judge, is not mentioned for this recall, and no MDL number, transfer order or Judicial Panel on Multidistrict Litigation (JPML) docket appears in the source material. No bellwether trial, a test case chosen to gauge how similar cases may resolve, is identified.

The recall itself is listed as Ongoing, meaning the FDA record does not yet show termination. No settlement, class action, verdict or appeal concerning the DxU 840m and DxU 850m Iris appears in the record.

For background on how device recall matters have proceeded elsewhere, see the analysis of the Philips CPAP and ventilator recall litigation and the Bair Hugger litigation overview. Both involve different devices and different courts.

Key dates

• August 12, 2026: Beckman Coulter initiated the recall, according to the recall initiation date in the FDA enforcement record.
• October 15, 2026: FDA classified the action as Class II (center classification date).
• October 21, 2026: FDA published the recall in its enforcement report (report date).
• October 21, 2026: The openFDA enforcement data set carrying the record was last updated.

What this does not establish

The record does not state how many instruments actually leaked, or whether any leak reached a person or caused injury. It does not identify a root cause beyond the maintenance scheduling issue described. It does not say whether FDA inspected the firm’s facility or issued a Form 483, a warning letter or any other compliance document. It does not state whether a corrected maintenance schedule has been issued, what the corrected interval is, or whether the firm has notified every customer. It does not address reimbursement, warranty coverage or service contracts.

The record also does not establish that any lawsuit has been filed, and it does not supply an MDL number. Health care professionals with questions about instrument servicing should consult the manufacturer’s instructions for use and their own service records; this article does not address any individual instrument or facility.

Frequently asked questions

What is the Beckman Coulter DxU 840m and 850m Iris recall?

It is FDA recall number Z-0160-2027, a Class II device recall covering the DxU 840m Iris (REF: C76947) and DxU 850m Iris (REF: C49513). FDA classified the action on October 15, 2026, and lists it as Ongoing. The stated reason is that the rinse-line check valve requires annual replacement and that replacement was excluded from annual preventive maintenance requirements without adequate reliability evaluation.

What does Class II mean for this Beckman Coulter recall?

Class II is an FDA recall classification for a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. The FDA enforcement record for recall Z-0160-2027 assigns Class II. The classification describes the agency’s assessment of risk, not a finding about any individual instrument or facility.

Has any lawsuit or MDL been filed over the DxU 840m and 850m Iris recall?

No federal consolidation of claims appears in the supplied records. No MDL number, JPML transfer order or bellwether trial schedule is identified for this recall. The FDA enforcement record covers only the regulatory action, not court proceedings.

How many units does recall Z-0160-2027 cover?

The FDA enforcement record lists a product quantity of 2,088 units. The code information states that all serial numbers are covered for both the DxU 840m and the DxU 850m. Distribution is listed as worldwide, including nationwide US distribution.

What hazards does the FDA record associate with the check valve?

The record states that if the check valve is not replaced annually, lamina fluid may migrate internally and leak onto the table or floor. It lists potential exposure to physical hazards such as slip or fall, chemical hazards from lamina fluid, biohazardous exposure, property damage, and delayed patient results. The record describes these as potential outcomes rather than confirmed events.

Sources

1. U.S. Food and Drug Administration (openFDA): “Device Enforcement Report for Recall Number Z-0160-2027” (link, accessed 2026-10-30)
2. U.S. Food and Drug Administration: “510(k) Premarket Notification Database” (link, accessed 2026-10-30)
3. U.S. Food and Drug Administration: “Medical Device Recalls Database” (link, accessed 2026-10-30)
4. U.S. Food and Drug Administration (openFDA): “Device Enforcement API, most recent record” (link, accessed 2026-10-30)
5. U.S. Food and Drug Administration (openFDA): “510(k) Device API, most recent record” (link, accessed 2026-10-30)
6. U.S. Food and Drug Administration: “Medical Devices” (link, accessed 2026-10-30)
7. U.S. Food and Drug Administration: “Device Advice: Comprehensive Regulatory Assistance” (link, accessed 2026-10-30)